These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20699026)

  • 1. [Genetic variations affect drug safety and efficacy].
    Harmsze AM; Deneer VH; Maitland-van der Zee AH; de Boer A; Klungel OH
    Ned Tijdschr Geneeskd; 2010; 154():A1503. PubMed ID: 20699026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
    Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
    Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics and the concept of individualized medicine.
    Shastry BS
    Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypersensitivity syndrome--the role of pharmacogenetics for prediction of efficacy and safety of antiretroviral therapy in patients with HIV/AIDS].
    Cholewińska G
    Przegl Epidemiol; 2008; 62(1):149-54. PubMed ID: 18536238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ontogeny and drug metabolism in newborns.
    Dotta A; Chukhlantseva N
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():83-4. PubMed ID: 22958028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochromes P450: decision-making tools for personalized therapeutics.
    Murray M; Petrovic N
    Curr Opin Mol Ther; 2006 Dec; 8(6):480-6. PubMed ID: 17243482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics: improving drug and dose selection.
    Bhathena A; Spear BB
    Curr Opin Pharmacol; 2008 Oct; 8(5):639-46. PubMed ID: 18762278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacogenomics: the quest for individualized therapy].
    López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
    Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Errors and reproducibility of DNA array-based detection of allelic variants in ADME genes: PHARMAchip.
    Cuyàs E; Olano-Martín E; Khymenets O; Hernández L; Jofre-Monseny L; Grandoso L; Tejedor D; Martínez A; Farré M; de la Torre R
    Pharmacogenomics; 2010 Feb; 11(2):257-66. PubMed ID: 20136364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [State of the art of pharmacogenetic diagnostics in drug therapy].
    Kirchheiner J; Seeringer A; Brockmöller J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):995-1003. PubMed ID: 17013776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacogenomics genomics approaches to optimizing drug therapy].
    Shi J; Chen S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Apr; 19(2):156-8. PubMed ID: 11941596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics and psychopharmacology.
    Bondy B; Zill P
    Curr Opin Pharmacol; 2004 Feb; 4(1):72-8. PubMed ID: 15018842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Customized drug therapy--how near is the goal?].
    Spigset O
    Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2390-6. PubMed ID: 16998553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics/genomics and personalized medicine.
    Sadée W; Dai Z
    Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R207-14. PubMed ID: 16244319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic testing for pharmacogenetics and its clinical application in drug therapy.
    Hiratsuka M; Sasaki T; Mizugaki M
    Clin Chim Acta; 2006 Jan; 363(1-2):177-86. PubMed ID: 16126184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics: the genomics of drug response.
    March R
    Yeast; 2000 Apr; 17(1):16-21. PubMed ID: 10797598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of disease-modifying anti-rheumatic drugs.
    Tanaka E; Taniguchi A; Urano W; Yamanaka H; Kamatani N
    Best Pract Res Clin Rheumatol; 2004 Apr; 18(2):233-47. PubMed ID: 15121042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics: progress, pitfalls and clinical potential for coronary heart disease.
    Humphries SE; Hingorani A
    Vascul Pharmacol; 2006 Feb; 44(2):119-25. PubMed ID: 16359930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population genetic structure of variable drug response.
    Wilson JF; Weale ME; Smith AC; Gratrix F; Fletcher B; Thomas MG; Bradman N; Goldstein DB
    Nat Genet; 2001 Nov; 29(3):265-9. PubMed ID: 11685208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.